Vimarsana
Biggest News Aggregation in the World

Page 3 - Upstream Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Upstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Upstream Processing Today - Breaking & Trending Today

Aldevron expands mRNA production capability - Vimarsana News

Aldevron expands mRNA production capability

Aldevron is expanding its mRNA production capabilities to include lipid nanoparticle (LNP) encapsulation and aseptic fill-finish capabilities.

Evolve Biologics $200m Texas facility set for 2024 completion date - Vimarsana News

Evolve Biologics $200m Texas facility set for 2024 completion date

Originally announced in 2021, the company expects the US facility for plasma treatments to be ready by the end of 2024.

Cytiva and Pall Life Sciences complete integration: 'Uniting gives us the focus, expertise, and talent to help our customers discover, develop, and deliver the next generations of novel therapeutics' - Vimarsana News

Cytiva and Pall Life Sciences complete integration: 'Uniting gives us the focus, expertise, and talent to help our customers discover, develop, and deliver the next generations of novel therapeutics'

Cytiva and the life sciences business of Pall Corporation are now united as one business under the Cytiva brand, with the completion of the integration announced this morning. Emmanuel Ligner, Danaher Group Executive, President and CEO of Cytiva, tells us how the company will focus its efforts moving forward to support long-term growth of the biotech industry.

Bristol Myers Squibb acquires US viral vector production facility from Novartis - Vimarsana News

Bristol Myers Squibb acquires US viral vector production facility from Novartis

Bristol Myers Squibb will boost its cell therapy manufacturing network with in-house viral vector production thanks to the acquisition of Novartis’ Libertyville, Illinois facility.

BioMarin opens €38m expansion at Irish manufacturing site - Vimarsana News

BioMarin opens €38m expansion at Irish manufacturing site

BioMarin Pharmaceutical has opened the expansion of its manufacturing plant at Shanbally, Co. Cork: with the site now able to provide end-to-end manufacturing for a number of the company’s commercial products.